Frontiers in Immunology (Apr 2020)

The Rules of Human T Cell Fate in vivo

  • Pedro Costa del Amo,
  • Bisrat Debebe,
  • Milad Razavi-Mohseni,
  • Shinji Nakaoka,
  • Shinji Nakaoka,
  • Andrew Worth,
  • Diana Wallace,
  • Peter Beverley,
  • Derek Macallan,
  • Becca Asquith

DOI
https://doi.org/10.3389/fimmu.2020.00573
Journal volume & issue
Vol. 11

Abstract

Read online

The processes governing lymphocyte fate (division, differentiation, and death), are typically assumed to be independent of cell age. This assumption has been challenged by a series of elegant studies which clearly show that, for murine cells in vitro, lymphocyte fate is age-dependent and that younger cells (i.e., cells which have recently divided) are less likely to divide or die. Here we investigate whether the same rules determine human T cell fate in vivo. We combined data from in vivo stable isotope labeling in healthy humans with stochastic, agent-based mathematical modeling. We show firstly that the choice of model paradigm has a large impact on parameter estimates obtained using stable isotope labeling i.e., different models fitted to the same data can yield very different estimates of T cell lifespan. Secondly, we found no evidence in humans in vivo to support the model in which younger T cells are less likely to divide or die. This age-dependent model never provided the best description of isotope labeling; this was true for naïve and memory, CD4+ and CD8+ T cells. Furthermore, this age-dependent model also failed to predict an independent data set in which the link between division and death was explored using Annexin V and deuterated glucose. In contrast, the age-independent model provided the best description of both naïve and memory T cell dynamics and was also able to predict the independent dataset.

Keywords